Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
28 January 2016
E-000674-16
Question for written answer
to the Commission
Rule 130
Ian Duncan (ECR)

 Subject:  Legal highs
 Answer(s) 

Concerns have been raised over the availability of new psychoactive substances (NPSs) through online sales. While it may not be possible to reach agreement on an EU-wide approach to this issue, there is merit in gaining a wider understanding of the challenges presented by NPSs. Does the Commission have plans to conduct a study to determine the extent of this problem?

Many NPSs are made in China and are then imported into Europe and marketed, as recognised by the EU’s own drug monitoring agency. What representations has the Commission made to China to help address this serious public health issue?

Last updated: 11 February 2016Legal notice